CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	Total Shareholders' Equity	Common Stock	Treasury Stock	Reinvested Earnings	Accumulated Other Comprehensive Income (Loss)	Non- controlling Interest - Preferred Stock  of Subsidiary
Beginning balance (in shares) at Dec. 31, 2022			1,987,784,948
Beginning balance at Dec. 31, 2022	$ 23,075	$ 22,823	$ 32,887	$ (2,517)	$ (7,542)	$ (5)	$ 252
Beginning balance, treasury (in shares) at Dec. 31, 2022				247,743,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	572	572			572
Other comprehensive income (loss)	5	5				5
Common stock issued, net (in shares)			7,989,135
Common stock issued, net	(610)	(610)	$ (610)
Treasury stock disposition (in shares)				(60,000,000)
Treasury stock disposition	610	610		$ 610
Stock-based compensation amortization	(63)	(63)	$ (63)
Preferred stock dividend requirement of subsidiary	(3)	(3)			(3)
Ending balance (in shares) at Mar. 31, 2023			1,995,774,083
Ending balance at Mar. 31, 2023	$ 23,586	23,334	$ 32,214	$ (1,907)	(6,973)	0	252
Ending balance, treasury (in shares) at Mar. 31, 2023				187,743,590
Beginning balance (in shares) at Dec. 31, 2023	2,133,597,758		2,133,597,758
Beginning balance at Dec. 31, 2023	$ 25,292	25,040	$ 30,374	$ 0	(5,321)	(13)	252
Beginning balance, treasury (in shares) at Dec. 31, 2023	0			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	$ 735	735			735
Other comprehensive income (loss)	(1)	(1)				(1)
Common stock issued, net (in shares)			3,558,470
Stock-based compensation amortization	(18)	(18)	$ (18)
Common stock dividends declared	(22)	(22)			(22)
Preferred stock dividend requirement of subsidiary	$ (3)	(3)			(3)
Ending balance (in shares) at Mar. 31, 2024	2,137,156,228		2,137,156,228
Ending balance at Mar. 31, 2024	$ 25,983	$ 25,731	$ 30,356	$ 0	$ (4,611)	$ (14)	$ 252
Ending balance, treasury (in shares) at Mar. 31, 2024	0			0